They demonstrated that orthotopic liver metastatic tumors in the presence of FGF2 were ineffective with BET inhibitor, and the combination of FGFR inhibitor and BET inhibitor significantly suppressed tumor growth in the liver microenvironment [16]. The gene discussed is DNER; the disease is neoplasm.